USD 24.98
(-7.03%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 18.31 Million USD | -52.91% |
2022 | 38.88 Million USD | 68.24% |
2021 | 23.11 Million USD | 145.22% |
2020 | 9.42 Million USD | 1613.45% |
2019 | 550 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 2.84 Million USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | -100.0% |
2013 | 10.6 Million USD | 0.0% |
2012 | 10.6 Million USD | -99.9% |
2011 | 10.12 Billion USD | 112022.05% |
2010 | 9.03 Million USD | -99.89% |
2009 | 7.88 Billion USD | 155695.56% |
2008 | 5.06 Million USD | 84.11% |
2007 | 2.75 Million USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 197.47 Thousand USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | -100.0% |
1999 | 14.05 Thousand USD | -84.39% |
1998 | 90.01 Thousand USD | -36.13% |
1997 | 140.93 Thousand USD | 0.0% |
1996 | - USD | -100.0% |
1995 | 22.65 Thousand USD | 0.0% |
1994 | - USD | 0.0% |
1993 | - USD | 0.0% |
1992 | - USD | 0.0% |
1991 | - USD | 0.0% |
1990 | - USD | 0.0% |
1989 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 10.45 Million USD | -33.35% |
2024 Q1 | 15.68 Million USD | -14.36% |
2023 Q1 | 38.9 Million USD | 0.05% |
2023 Q2 | 39.29 Million USD | 1.0% |
2023 FY | 18.31 Million USD | -52.91% |
2023 Q4 | 18.31 Million USD | -48.94% |
2023 Q3 | 35.86 Million USD | -8.72% |
2022 Q1 | 22.48 Million USD | -2.71% |
2022 Q3 | 38.84 Million USD | 79.8% |
2022 Q2 | 21.6 Million USD | -3.9% |
2022 FY | 38.88 Million USD | 68.24% |
2022 Q4 | 38.88 Million USD | 0.09% |
2021 FY | 23.11 Million USD | 145.22% |
2021 Q1 | 10.53 Million USD | 11.75% |
2021 Q2 | 20.86 Million USD | 98.08% |
2021 Q3 | 21.49 Million USD | 3.06% |
2021 Q4 | 23.11 Million USD | 7.5% |
2020 FY | 9.42 Million USD | 1613.45% |
2020 Q3 | 26 Thousand USD | -77.59% |
2020 Q1 | 332 Thousand USD | -39.64% |
2020 Q2 | 116 Thousand USD | -65.06% |
2020 Q4 | 9.42 Million USD | 36146.15% |
2019 FY | 550 Thousand USD | 0.0% |
2019 Q2 | 816 Thousand USD | -17.82% |
2019 Q4 | 550 Thousand USD | -27.54% |
2019 Q3 | 759 Thousand USD | -6.99% |
2019 Q1 | 993 Thousand USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 FY | - USD | -100.0% |
2017 Q4 | - USD | 0.0% |
2017 Q2 | - USD | -100.0% |
2017 Q1 | 3.93 Million USD | 38.45% |
2016 Q1 | - USD | 0.0% |
2016 FY | 2.84 Million USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | 2.84 Million USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q1 | - USD | -100.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | -100.0% |
2014 Q4 | - USD | 0.0% |
2013 Q3 | 10.6 Million USD | 0.0% |
2013 Q1 | 10.6 Million USD | 0.0% |
2013 FY | 10.6 Million USD | 0.0% |
2013 Q4 | 10.6 Million USD | 0.0% |
2013 Q2 | 10.6 Million USD | 0.0% |
2012 FY | 10.6 Million USD | -99.9% |
2012 Q4 | 10.6 Million USD | 0.0% |
2012 Q3 | 10.6 Million USD | 0.0% |
2012 Q2 | 10.6 Million USD | 2.91% |
2012 Q1 | 10.3 Million USD | -99.9% |
2011 FY | 10.12 Billion USD | 112022.05% |
2011 Q1 | 9.38 Million USD | 3.87% |
2011 Q2 | 9.65 Million USD | 2.88% |
2011 Q3 | 9.9 Million USD | 2.59% |
2011 Q4 | 10.12 Billion USD | 102172.01% |
2010 Q1 | - USD | -100.0% |
2010 FY | 9.03 Million USD | -99.89% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | 9.03 Million USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 FY | 7.88 Billion USD | 155695.56% |
2009 Q1 | - USD | -100.0% |
2009 Q4 | 7.88 Billion USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 Q4 | 5.06 Million USD | 13.44% |
2008 FY | 5.06 Million USD | 84.11% |
2008 Q2 | 3.96 Million USD | 14.44% |
2008 Q3 | 4.46 Million USD | 12.62% |
2008 Q1 | 3.46 Million USD | 25.93% |
2007 Q4 | 2.75 Million USD | 266.67% |
2007 Q1 | 750 Thousand USD | 0.0% |
2007 Q2 | 750 Thousand USD | 0.0% |
2007 Q3 | 750 Thousand USD | 0.0% |
2007 FY | 2.75 Million USD | 0.0% |
2006 Q1 | 190.14 Thousand USD | -3.72% |
2006 Q4 | - USD | -100.0% |
2006 Q2 | 182.71 Thousand USD | -3.91% |
2006 FY | - USD | -100.0% |
2006 Q3 | 175.18 Thousand USD | -4.12% |
2005 FY | 197.47 Thousand USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q3 | 204.72 Thousand USD | 0.0% |
2005 Q4 | 197.47 Thousand USD | -3.54% |
2004 Q3 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2002 Q3 | - USD | -100.0% |
2002 Q4 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q2 | 80.82 Thousand USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2000 Q2 | 5472.00 USD | -98.92% |
2000 Q4 | - USD | -100.0% |
2000 FY | - USD | -100.0% |
2000 Q3 | 2728.00 USD | -50.15% |
2000 Q1 | 508.15 Thousand USD | 4981.54% |
1999 Q3 | 20 Thousand USD | -33.33% |
1999 Q1 | 40 Thousand USD | -55.56% |
1999 Q4 | 10 Thousand USD | -50.0% |
1999 Q2 | 30 Thousand USD | -25.0% |
1999 FY | 14.05 Thousand USD | -84.39% |
1998 FY | 90.01 Thousand USD | -36.13% |
1998 Q1 | 100 Thousand USD | -29.05% |
1998 Q2 | 100 Thousand USD | 0.0% |
1998 Q3 | 100 Thousand USD | 0.0% |
1998 Q4 | 90.01 Thousand USD | -9.99% |
1997 Q4 | 140.93 Thousand USD | 181.87% |
1997 Q2 | - USD | 0.0% |
1997 Q1 | - USD | 0.0% |
1997 FY | 140.93 Thousand USD | 0.0% |
1997 Q3 | 50 Thousand USD | 0.0% |
1996 FY | - USD | -100.0% |
1996 Q1 | - USD | 0.0% |
1996 Q2 | 4632.00 USD | 0.0% |
1996 Q3 | - USD | -100.0% |
1995 Q4 | - USD | 0.0% |
1995 Q1 | 1 Million USD | 0.0% |
1995 FY | 22.65 Thousand USD | 0.0% |
1995 Q2 | 22.65 Thousand USD | -97.73% |
1995 Q3 | - USD | -100.0% |
1994 Q2 | - USD | 0.0% |
1994 Q3 | - USD | 0.0% |
1994 Q1 | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1993 Q4 | - USD | 0.0% |
1993 FY | - USD | 0.0% |
1993 Q3 | - USD | 0.0% |
1993 Q2 | - USD | 0.0% |
1993 Q1 | - USD | -100.0% |
1992 FY | - USD | 0.0% |
1992 Q3 | 100 Thousand USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 Q4 | 100 Thousand USD | 0.0% |
1991 Q4 | - USD | 0.0% |
1991 FY | - USD | 0.0% |
1991 Q2 | - USD | 0.0% |
1990 Q3 | - USD | 0.0% |
1990 Q2 | - USD | 0.0% |
1990 FY | - USD | 0.0% |
1989 FY | - USD | 0.0% |
1989 Q2 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | 75.668% |
AngioDynamics, Inc. | 3.93 Million USD | -364.864% |
AtriCure, Inc. | 60.59 Million USD | 69.78% |
Avinger, Inc. | - USD | -Infinity% |
Azenta, Inc. | 60.43 Million USD | 69.702% |
The Cooper Companies, Inc. | 2.52 Billion USD | 99.274% |
Daxor Corporation | 755.65 Thousand USD | -2323.183% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | -278.953% |
Femasys Inc. | 4.25 Million USD | -330.019% |
GlucoTrack, Inc. | 196 Thousand USD | -9242.347% |
Harvard Bioscience, Inc. | 30.7 Million USD | 40.363% |
Hologic, Inc. | 2.49 Billion USD | 99.267% |
ICU Medical, Inc. | 1.57 Billion USD | 98.839% |
Intuitive Surgical, Inc. | -82.1 Million USD | 122.303% |
KORU Medical Systems, Inc. | 3.65 Million USD | -401.27% |
LeMaitre Vascular, Inc. | 16.62 Million USD | -10.148% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 871.7 Million USD | 97.899% |
Microbot Medical Inc. | 40 Thousand USD | -45677.5% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -398658.711% |
Merit Medical Systems, Inc. | 823.01 Million USD | 97.775% |
Nephros, Inc. | 1.39 Million USD | -1217.338% |
NovoCure Limited | 596.24 Million USD | 96.929% |
NEXGEL, Inc. | 513 Thousand USD | -3469.396% |
NEXGEL, Inc. | 513 Thousand USD | -3469.396% |
Singular Genomics Systems, Inc. | 67.52 Million USD | 72.882% |
OraSure Technologies, Inc. | 11.38 Million USD | -60.792% |
Pro-Dex, Inc. | 7.53 Million USD | -142.98% |
Pulse Biosciences, Inc. | 8.08 Million USD | -126.453% |
Predictive Oncology Inc. | 2.18 Million USD | -736.509% |
Precision Optics Corporation, Inc. | 1.93 Million USD | -844.855% |
QuidelOrtho Corporation | 2.27 Billion USD | 99.195% |
Repligen Corporation | 510.14 Million USD | 96.411% |
Sanara MedTech Inc. | 9.11 Million USD | -100.93% |
STAAR Surgical Company | 31.46 Million USD | 41.809% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 295 Thousand USD | -6107.119% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 98.98% |
Jin Medical International Ltd. | - USD | -Infinity% |